1c options are enticing, they seem to make up for this year’s options which look like going under unless there are some positive announcements in the last 4 weeks of the year.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
